Seung-Jae Noh

Seung-Jae Noh

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
JKJeong Yeon Kim
Jeong Yeon Kim
HBHyoeun Bang
Hyoeun Bang
SNSeung-Jae Noh
Seung-Jae Noh
JCJung Kyoon Choi
Jung Kyoon Choi
Non-self epitopes, whether originated from foreign substances or somatic mutations, trigger immune responses when presented by major histocompatibility complex (MHC) molecules and recognized by T cells. Identification of immunogenically active neoepitopes has significant implications in cancer and virus medicine. However, current methods are mostly limited to predicting physical binding of mutant peptides and MHCs. We previously developed a deep-learning based model, DeepNeo, to identify immunogenic neoepitopes by capturing the structural properties of peptide-MHC pairs with T cell reactivity. Here, we upgraded our DeepNeo model with up-to-date training data. The upgraded model (DeepNeo-v2) was improved in evaluation metrics and showed prediction score distribution that better fits known neoantigen behavior. The immunogenic neoantigen prediction can be conducted at https://deepneo.net.

16 November 2012 in Blood
Verified
Journal Article
Open access
JVJaira F. de Vasconcellos
Jaira F. de Vasconcellos
YLY. Terry Lee
Y. Terry Lee
JYJoan Yuan
Joan Yuan
CBColleen Byrnes
Colleen Byrnes
SNSeung-Jae Noh
Seung-Jae Noh
JMJeffery L. Miller
Jeffery L. Miller
Abstract 827 The highly-conserved Lin28 genes regulate cellular metabolism as well as the timing of developmental events and cell fates in multicellular organisms. Lin28 protein acts primarily by negatively regulating biogenesis of let-7 RNA, a microRNA family whose targets include growth-related signaling and transcription factor proteins. Published studies showed significantly increased expression of let-7 in purified adult blood reticulocytes compared to umbilical cord blood reticulocytes (1). This pattern correlates inversely with Lin28B expression. While present in the fetal liver and umbilical cord blood, Lin28B decreased to undetectable levels in adult bone marrow (2). Based upon the association of human ontogeny with hemoglobin switching, Lin28 was explored to identify novel mechanisms for hemoglobin regulation that may be useful for therapeutic application among patients with thalassemia or other hemoglobinopathies. To study the effects of Lin28B upon erythropoiesis and hemoglobin, ectopic expression of Lin28B was accomplished using retroviral transduction of human CD34+ cells cultivated ex vivo in erythropoietin-supplemented, serum-free cultures for 21 days. All experiments were performed in triplicate using cells from three separate adult volunteers. Lin28B over-expression (Lin28B-OE) was confirmed by Q-RT-PCR (control: 0.14 ± 0.37 copies/ng, Lin28B-OE: 1.8E+04 ± 353.8 copies/ng, p=0.01). Western analyses confirmed protein expression, and confocal microscopy revealed Lin28B predominantly in the cytoplasm of the transduced cells. Proliferation, maturation and morphology assays revealed that Lin28B-OE did not inhibit erythropoiesis when compared to control (empty vector) transductions. Terminal maturation with loss of CD71 from the erythroblast surface and enucleation by culture day 21 was detected in the control and Lin28B-OE samples. Expression levels of globin genes were evaluated upon Lin28B-OE by Q-RT-PCR. Lin28B-OE enhances gamma-globin mRNA expression (control: 5.14E+06 ± 2.6E+06 copies/ng, Lin28B-OE: 1.81E+07 ± 5.82E+06 copies/ng, p=0.038). Protein analysis confirmed the increased expression of gamma-globin. Fetal hemoglobin (HbF) levels were also increased in the Lin28B-OE cultures (control: 5.82 ± 4.54%, Lin28B-OE: 33.63 ± 9.38%; p=0.011). The increased HbF expression was maintained throughout differentiation including enucleated populations of culture-generated erythrocytes. Possible mechanism(s) for the increased expression of HbF caused by Lin28B-OE were investigated. Q-RT-PCR analyses demonstrated suppression of the let-7 microRNA family with greater-than 70% reductions of let-7a, let-7b, let-7c, let-7d, let-7e, let-7f-2, let-7g and let-7i. Expression patterns of several transcription factors including BCL11A, KLF1, SOX6 and GATA1 were explored. No major changes were detected with the exception of BCL11A. Lin28B-OE caused a 65% reduction in BCL11A expression (control: 3.07E+03 ± 1.5E+02 copies/ng, Lin28B-OE: 1.07E+03 ± 18 copies/ng; p=0.02). Western blot analyses of Lin28B-OE showed a consistent reduction of BCL11A protein. By comparison with Lin28B-OE, separately performed studies of BCL11A knockdown in adult CD34+ cells produced comparable increases in gamma-globin expression, but Lin28B expression in those cells was not affected. In addition to a more general role in development and metabolism, these experimental results suggest that Lin28B increases fetal hemoglobin and regulates BCL11A in human erythroblasts. Lin28B is thus identified as the first defined link between the regulation of a developmental clock and hemoglobin switching in humans.

Verified
Journal Article
Open access
PDF file
ELEun Ji Lee
Eun Ji Lee
SNSeung-Jae Noh
Seung-Jae Noh
HCHuiseon Choi
Huiseon Choi
MKMin Woo Kim
Min Woo Kim
SKSu Jin Kim
Su Jin Kim
Suhwan ChangSuhwan Chang
Suhwan Chang
Tissue-specific gene expression generates fundamental differences in the function of each tissue and affects the characteristics of the tumors that are created as a result. However, it is unclear how much the tissue specificity is conserved during grafting of the primary tumor into an immune-compromised mouse model. Here, we performed a comparative RNA-seq analysis of four different primary-patient derived xenograft (PDX) tumors. The analysis revealed a conserved RNA biotype distribution of primary−PDX pairs, as revealed by previous works. Interestingly, we detected significant changes in the splicing pattern of PDX, which was mainly comprised of skipped exons. This was confirmed by splicing variant-specific RT-PCR analysis. On the other hand, the correlation analysis for the tissue-specific genes indicated overall strong positive correlations between the primary and PDX tumor pairs, with the exception of gastric cancer cases, which showed an inverse correlation. These data propose a tissue-specific change in splicing events during PDX formation as a variable factor that affects primary−PDX integrity.

1 June 2026 in Translational Lung Cancer Research
Verified
Journal Article
Open access
PDF file
HKHee Joung Kim
Hee Joung Kim
JHJae Young Hur
Jae Young Hur
WKWan Seop Kim
Wan Seop Kim
IKIn Ae Kim
In Ae Kim
DPDongil Park
Dongil Park
KLKye Young Lee
Kye Young Lee
Background: Obtaining sufficient tumor tissue for molecular testing remains challenging in advanced non-small cell lung cancer (NSCLC). We evaluated tumor mutation burden (TMB) using extracellular vesicle (EV)-derived DNA from bronchoalveolar lavage fluid (BALF) and assessed the correlation between BALF and tissue TMB. Methods: In this prospective, multicenter, observational study, we enrolled patients with pathologically confirmed stage IV NSCLC who received pembrolizumab at three academic institutions in South Korea. TMB was quantified by whole-exome sequencing (WES) of EV-derived DNA isolated from BALF and from matched tumor tissue obtained prior to treatment. The concordance of TMB between BALF EV-derived DNA and matched tumor tissue was assessed using Spearman’s rank correlation coefficient. Associations between BALF EV-TMB and clinical outcomes—including overall survival (OS), progression-free survival (PFS), and objective response rate—were evaluated over a median follow-up of 17.0 months (range, 1–63 months). Results: Out of 64 patients, 46 (71.9%) had evaluable tissue TMB, and 53 (82.8%) had evaluable BALF TMB. There were no significant differences between BALF and tissue regarding DNA amounts, estimated library size, mean depth, and uniformity. The median tissue TMB and BALF TMB were 4.738 and 1.82 mut/Mb, respectively. A modest positive correlation was observed between tissue TMB and BALF TMB (r=0.61, P<0.001). Neither tissue TMB nor BALF TMB showed significant differences in PFS. However, higher TMB is associated with a more favorable OS outcome in patients with advanced NSCLC. Conclusions: These findings demonstrate the feasibility of WES-based TMB quantification from BALF EV-derived DNA and suggest its potential as a complementary prognostic measure in pembrolizumab-treated NSCLC. Validation in larger, prospective cohorts is warranted before clinical implementation.